TrialStem cells translational medicine2021

Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial.

Giacomo Lanzoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.